With clients ranging from multinational companies to entrepreneurial start-ups, the patent practice offers legal services in virtually
every aspect of patent law. Representative clients include leaders in the fields of financial and information services, software
development, consumer electronics and other goods, chemicals, pharmaceuticals, telecommunications, entertainment,nanotechnology software and technology, e-commerce, real estate and arts/education/non-profit. Kelley Drye has patent professionals
in most of its offices, with a concentration in Stamford, Chicago and Washington, DC.
Kelley Drye’s patent practice includes a diverse group of attorneys and patent agents with technological backgrounds in the electrical,
mechanical and chemical arenas. Most of Kelley Drye’s patent professionals have significant experience in industry and/or academia.
Many have advanced degrees (Master, Ph.D.) in their technological fields, and are experienced scientists and engineers.
Our patent litigation experience includes the following:
Summary judgment granted to client in action against the USPTO on proposed rule changes relating to limitations on the number
of patent claims and continuations in an application.
Attorneys in Kelley Drye’s Hatch-Waxman practice have a deep understanding of the drug approval and development process and
are able to guide clients through the complexities of the Drug Price Competition and Patent Term Restoration Act (better known as the
“Hatch-Waxman” Act), including its attendant intellectual property, technical, regulatory and antitrust aspects. Representative litigation
Abbott Laboratories v. Mylan Inc.
(N.D. Ill) (lopinavir/ritonavir)Abbott Laboratories v. Novartis Nutrition
(N.D. Ill) (nutritional supplement)Abbott v. Zydus Pharmaceuticals (USA) Inc.
(D.N.J.) (Depakote E.R)AHP v. Upjohn Co.
(D.N.J.) (canine vaccine)AstraZeneca Pharmaceuticals LP v. Sandoz, Inc
. (D.N.J. and Fed. Cir) (quetiapine)AstraZeneca Pharmaceuticals LP v. Lupin Pharmaceuticals
(D.N.J.) (esomeprazole)AstraZeneca LP v. Lek Pharmaceuticals
(S.D.N.Y.) (omeprazole)Cephalon, Inc. v. Sandoz, Inc
. (D.N.J.) (modafinil)Elan v. Corepharma
(E.D.N.Y.) (metaxalone)Eli Lilly and Company v. Zydus Pharmaceuticals (USA) Inc.
(D.N.J.) (Strattera)Forest Laboratories v. Lupin Pharmaceuticals
(D. Del.) (memantine)Organon Pharmaceuticals v. Geneva Pharmaceuticals
(D.N.J.) (mirtazapine)Orexo AB v. Mylan Inc.
(S.D.N.Y.) (zolpidem)Pfizer, Inc. v. Geneva Pharmaceuticals
(D.N.J.) (gabapentin)Pfizer, Inc. v. Sandoz, Inc
. (D. Del.) (azithromycin)RCT v. Ben Venue Laboratories
(D.N.J.) (cisplatin)Sanofi v. Sandoz, Inc.
(D.N.J. and Fed Cir.) (oxaliplatin)Schering-Plough v. Geneva Pharmaceuticals
(D.N.J. and Fed. Cir.) (loratadine)Sciele Pharma, Inc. v. Lupin Pharmaceuticals
(D. Del.) (metformin)Sepracor, Inc. v. Lupin Pharmaceuticals
(D.N.J.) (eszopiclone)Shionogi, Inc. v. Lupin Pharmaceuticals
(D. Del.) (metformin)Shire Pharmaceuticals v. Mylan Inc.
(S.D.N.Y.) (lanthanum carbonate)Taro Pharmaceuticals v. Synerx Pharma
, LLC (D.N.J.) (malathion lotion)Teva Women's Health v. Lupin Pharmaceuticals, Inc., et al.
(D.N.J.) (oral contraceptives)Teva v. Zydus Pharmaceuticals (USA) Inc.
(D.N.J.) (carvedilol)Three Rivers Pharmaceuticals v. Zydus Pharmaceuticals (USA) Inc.
(E.D.Va.) (ribavirin)Warner Chilcott v. Lupin Pharmaceuticals
(D. Del.) (oral contraceptives)
Successful assertion of Swedish shipping company's patent on ship hull design against the United States resulting in award of$3.2 million to client.
Successful defense of patent infringement suit. Settlement negotiated after Markman briefing and argument.
Represented defendant in patent infringement case pertaining to a phosphor and preparation process.
Successful defense of patent infringement suit; following Markman ruling construing claims in client’s favor, summary judgmentmotion granted dismissing suit.
Represented plaintiff in patent infringement suit involving a speaker independent system for unified communications viatelephone and Internet.
Successful defense of patent infringement action resulting in license to client for nominal fee.
Obtained an emergency stay followed by a judgment vacating preliminary injunction entered in the Northern District of California.
Successful settlement of claims asserting the world's largest semiconductor chip maker's chipset patents against foreigninfringer.
398 Pomfret Street, P.O. Box 128, Pomfret CT 06258-0128 860-963-6100 PRESS RELEASE For Immediate Release Contact: John Director of Communications & Public Relations All Invited to Pomfret School’s “La Serva Padrona” Pomfret, CT - Guests are invited to attend Pomfret School’s spring operatic production of Giovanni Battista Pergolesi’s “La Serva Padrona” on F
MASENO UNIVERSITY SCHOOL OF GRADUATE STUDIES UNIVERSITY EXAMINATION RESULTS 2011/2012 SCHOOL OF PUBLIC HEALTH AND COMMUNITY DEVELOPMENT GRADUATION LIST The following TWENTY THREE (23) candidates SATISFIED the Board of Examiners of the School of Public Health and Community Development and the School of Graduate Studies in their postgraduate degree programmes and are